Skip to main content

New York

Public Health Trace has 23,291 recall records and 3,306 outbreak investigations on file connected to New York, with 107,237 reported illnesses across those outbreak investigations, republished from official FDA, USDA, and CDC sources.

23,291
Recalls distributed here
3,306
Outbreaks affecting this state
107,237
Reported illnesses
Recalls and outbreaks by year

A bar chart of recall and outbreak counts affecting this state by year, built from the complete yearly totals for this state, not a bounded preview.

  • Recalls
  • Outbreaks
Download CSV
View full recalls and outbreaks by year (56 years)
Recalls and outbreaks by year
YearRecallsOutbreaks
197101
197201
197300
197402
197500
197601
197700
197808
197901
198002
198102
198204
198300
198404
198503
198601
198700
198801
198906
199002
199100
199204
199301
199403
199506
199603
199705
1998074
1999056
2000065
2001060
2002054
2003043
2004064
2005063
2006083
2007055
2008058
20090290
20100337
20110336
2012396286
20131,152273
201472465
20151,743294
20161,876246
20172,439205
20181,62574
20192,73962
20201,32218
20211,12924
20222,17635
20232,29325
20241,3030
20251,2390
20261,1350

CDC NORS is a historical archive currently available through 2023; later zeros do not mean no outbreaks occurred.

Recall records distributed in New York

Newest reported records first. Each record's own status (active, terminated, or not reported) is shown on its card.

FDA Recall Ongoing2026 recordClass II

Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-1318-3

by Apotex Corp.

Reason
Failed dissolution specifications.
Published
October 7, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Buprenorphine Hydrochloride, Injection 0.3 mg/mL, Rx Only, 5 x 1 mL Single Dose Vials, Manufactured for: Endo USA, Malvern, PA, NDC 42023-179-05

by Par Health USA, LLC

Reason
Crystallization
Published
October 7, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Zoladex (goserelin) implant, 3.6 mg, One single-Use Syringe packaged in a carton, Rx only, Manufactured for: TerSera therapeutics LLC, Deerfield, IL 60015, BY: AstraZeneca UK Limited, Macclesfield, England, Product of Switzerland, website at www.zoladex.com, NDC 70720-950-36.

by TerSera Therapeutics LLC

Reason
Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours.
Published
October 7, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08907, NDC 69238-2452-3.

by Amneal Pharmaceuticals, LLC

Reason
Defective Container; packets were found to be either empty or partially full.
Published
October 7, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02

by Ajanta Pharma USA Inc

Reason
Failed Dissolution Specifications: below specification
Published
October 7, 2026
Distribution
Nationwide

View recall →

FDA Recall United States Ongoing2026 recordClass I

TODD'S SEEDS LLC

Product
Todd's Seeds Variety Pack of Sprouting Seeds - Broccoli, Alf…
Reason
Products contain alfalfa seed recalled by the supplier and may be contaminated with E. coli and/or Salmonella (downstream recall)
Published
October 7, 2026
Distribution
Nationwide

View recall →

Showing 6 of 23,291 recall records

See all recalls in New York

Outbreak records affecting New York

Newest reported records first. Each record's own status (active investigation, historical, or monitoring) is shown on its card.

Showing 6 of 3,306 outbreak records

See all outbreaks in New York

Companies with recalls distributed in New York

Via the real distribution-state record on each recall -- distinct from the free-text match used for the recall cards above.

CDC announcements naming New York

Only announcements with an explicit, normalized relationship to New York are shown -- see our methodology.

Disease surveillance trends

No disease surveillance trend data has been published for this state.

Data availability

Disease surveillance trends are only shown where CDC's reporting areas have been matched to this state. A state showing no surveillance data here may still have real recalls and outbreaks above - the gap is in state-level linkage for weekly case reports specifically, not an indication that nothing was reported.

Freshness unavailable for one or more included sources

This page combines recall records from the FDA and USDA with outbreak investigations and disease surveillance data from the CDC. It is not a safety ranking or comparison between states -- a higher count here can reflect more thorough reporting as much as more actual events, and is not a statement that New York is more or less safe than any other state. Read the full medical disclaimer.